MENU
+Compare
RNXT
Stock ticker: NASDAQ
AS OF
Sep 17, 04:59 PM (EDT)
Price
$1.23
Change
-$0.03 (-2.38%)
Capitalization
46.54M

RNXT RenovoRx Forecast, Technical & Fundamental Analysis

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RNXT with price predictions
Sep 16, 2025

RNXT's RSI Indicator recovers from oversold territory

The RSI Oscillator for RNXT moved out of oversold territory on August 22, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 29, 2025. You may want to consider a long position or call options on RNXT as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RNXT just turned positive on September 02, 2025. Looking at past instances where RNXT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

RNXT moved above its 50-day moving average on September 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RNXT crossed bullishly above the 50-day moving average on September 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RNXT advanced for three days, in of 181 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 35 cases where RNXT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for RNXT moved below the 200-day moving average on September 10, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RNXT broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RNXT entered a downward trend on August 19, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RNXT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.338) is normal, around the industry mean (20.607). P/E Ratio (0.000) is within average values for comparable stocks, (53.283). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (56.180) is also within normal values, averaging (333.412).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNXT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RNXT is expected to report earnings to -7 cents per share on November 17

RenovoRx RNXT Stock Earnings Reports
Q3'25
Est.
$-0.08
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.02
The last earnings report on August 14 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 344.86K shares outstanding, the current market capitalization sits at 46.54M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLB71.890.09
+0.13%
Dolby Laboratories IncClass A
MLSS0.58N/A
-0.07%
Milestone Scientific
GIC36.93-0.14
-0.38%
Global Industrial Company
ABBV216.26-1.35
-0.62%
ABBVIE
NL6.08-0.14
-2.25%
NL Industries

RNXT and Stocks

Correlation & Price change

A.I.dvisor tells us that RNXT and TARA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and TARA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-0.79%
TARA - RNXT
30%
Poorly correlated
-2.85%
CYTK - RNXT
28%
Poorly correlated
+0.65%
IMRX - RNXT
26%
Poorly correlated
+5.73%
RVMD - RNXT
26%
Poorly correlated
-3.25%
CRNX - RNXT
25%
Poorly correlated
+0.98%
More